Cargando…

Stem Cell-Based Cell Therapy for Glomerulonephritis

Glomerulonephritis (GN), characterized by immune-mediated inflammatory changes in the glomerular, is a common cause of end stage renal disease. Therapeutic options for glomerulonephritis applicable to all cases mainly include symptomatic treatment and strategies to delay progression. In the attempt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Meiling, Xie, Yuansheng, Li, Qinggang, Chen, Xiangmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070530/ https://www.ncbi.nlm.nih.gov/pubmed/25003105 http://dx.doi.org/10.1155/2014/124730

Ejemplares similares

Glomerular filtration rate measured by (99m)Tc‐DTPA renal dynamic imaging is significantly lower than that estimated by the CKD‐EPI equation in horseshoe kidney patients
por: Qi, Yan, et al.
Publicado: (2016)

System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease
por: Jin, Meiling, et al.
Publicado: (2016)

Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions
por: Hu, Jie, et al.
Publicado: (2013)

Suppressor of Cytokine Signaling-1/STAT1 Regulates Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models
por: Bai, Jiuxu, et al.
Publicado: (2018)

Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next‐generation sequencing technology
por: Wang, Tao, et al.
Publicado: (2019)

Modulation of cyclins and p53 in mesangial cell proliferation and apoptosis during Habu nephritis
por: Lu, Yang, et al.
Publicado: (2015)

Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury
por: Fu, Zhangning, et al.
Publicado: (2023)

Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis
por: Guo, Ling, et al.
Publicado: (2017)

Parietal epithelial cell dysfunction in crescentic glomerulonephritis
por: Wong, Milagros N., et al.
Publicado: (2021)

Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
por: Linke, Alexandra, et al.
Publicado: (2022)

Acute glomerulonephritis in a hematopoietic blood stem cell donor
por: Chandra, Preeti, et al.
Publicado: (2021)

A single‐cell survey of the human glomerulonephritis
por: Chen, Zhejun, et al.
Publicado: (2021)

Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis
por: Quaglia, Marco, et al.
Publicado: (2022)

The role of Th1 and Th17 cells in glomerulonephritis
por: Azadegan-Dehkordi, Fatemeh, et al.
Publicado: (2015)

PD-1 immunobiology in glomerulonephritis and renal cell carcinoma
por: Curran, Colleen S., et al.
Publicado: (2021)

Crescentic Glomerulonephritis: Pathogenesis and Therapeutic Potential of Human Amniotic Stem Cells
por: Al Mushafi, Ahmed, et al.
Publicado: (2021)

Stem cell-based therapy for ameliorating intrauterine adhesion and endometrium injury
por: Song, Yu-Ting, et al.
Publicado: (2021)

Membranoproliferative glomerulonephritis
por: Alchi, Bassam, et al.
Publicado: (2009)

Hypertension in Chronic Glomerulonephritis
por: Ihm, Chun-Gyoo
Publicado: (2015)

Fibrillary Glomerulonephritis: An Update
por: Rosenstock, Jordan L., et al.
Publicado: (2019)

Vitamin D and Glomerulonephritis
por: Gembillo, Guido, et al.
Publicado: (2021)

The Role of Inflammasomes in Glomerulonephritis
por: Anton-Pampols, Paula, et al.
Publicado: (2022)

Mesenchymal Stem Cells Attenuate Peritoneal Injury through Secretion of TSG-6
por: Wang, Nan, et al.
Publicado: (2012)

Infection-Related Glomerulonephritis
por: Khalighi, Mazdak A., et al.
Publicado: (2021)

Glomerulonephritis: immunopathogenesis and immunotherapy
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

Mesenchymal stem cells-based therapy in liver diseases
por: Han, Heng-Tong, et al.
Publicado: (2022)

Stem Cell-Based Therapies for Inflammatory Bowel Disease
por: Zhang, Hua-Min, et al.
Publicado: (2022)

Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6
por: Wang, Nan, et al.
Publicado: (2012)

Treatment of Primary Glomerulonephritis
por: Oliveira, David B G
Publicado: (1997)

Novel targets for immunotherapy in glomerulonephritis
por: Foster, Mary H
Publicado: (2008)

CTGF in kidney fibrosis and glomerulonephritis
por: Toda, Naohiro, et al.
Publicado: (2018)

The role of Treg subtypes in glomerulonephritis
por: Herrnstadt, G. R., et al.
Publicado: (2020)

Immunosenescence: an unexplored role in glomerulonephritis
por: Van Laecke, Steven, et al.
Publicado: (2022)

Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017)

Recurrence of primary glomerulonephritis: Review of the current evidence
por: Abbas, Fedaey, et al.
Publicado: (2017)

Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy
por: Cruz-Whitley, Jessica, et al.
Publicado: (2020)

An Approach to the Child with Acute Glomerulonephritis
por: Welch, Thomas R.
Publicado: (2012)

Recurrent Glomerulonephritis in the Kidney Allograft
por: Bobart, Shane A., et al.
Publicado: (2020)

Rapidly progressive glomerulonephritis in children
por: Moorani, Khemchand N, et al.
Publicado: (2022)

Insights into new-onset autoimmune diseases after COVID-19 vaccination
por: Guo, Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mtapjs959cnrpljaho0ne7oc4g